FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553261268> ?p ?o ?g. }

• W2553261268 endingPage "225" @default.
• W2553261268 startingPage "215" @default.
• W2553261268 abstract "Healthy kidneys filter ∼160 g/day of glucose (∼30% of daily energy intake) under euglycaemic conditions. To prevent valuable energy from being lost in the urine, the proximal tubule avidly reabsorbs filtered glucose up to a limit of ∼450 g/day. When blood glucose levels increase to the point that the filtered load exceeds this limit, the surplus is excreted in the urine. Thus, the kidney provides a safety valve that can prevent extreme hyperglycaemia as long as glomerular filtration is maintained. Most of the capacity for renal glucose reabsorption is provided by sodium glucose cotransporter (SGLT) 2 in the early proximal tubule. In the absence or with inhibition of SGLT2, the renal reabsorptive capacity for glucose declines to ∼80 g/day (the residual capacity of SGLT1), i.e. the safety valve opens at a lower threshold, which makes it relevant to glucose homeostasis from day-to-day. Several SGLT2 inhibitors are now approved glucose lowering agents for individuals with type 2 diabetes and preserved kidney function. By inducing glucosuria, these drugs improve glycaemic control in all stages of type 2 diabetes, while their risk of causing hypoglycaemia is low because they naturally stop working when the filtered glucose load falls below ∼80 g/day and they do not otherwise interfere with metabolic counterregulation. Through glucosuria, SGLT2 inhibitors reduce body weight and body fat, and shift substrate utilisation from carbohydrates to lipids and, possibly, ketone bodies. Because SGLT2 reabsorbs sodium along with glucose, SGLT2 blockers are natriuretic and antihypertensive. Also, because they work in the proximal tubule, SGLT2 inhibitors increase delivery of fluid and electrolytes to the macula densa, thereby activating tubuloglomerular feedback and increasing tubular back pressure. This mitigates glomerular hyperfiltration, reduces the kidney's demand for oxygen and lessens albuminuria. For reasons that are less well understood, SGLT2 inhibitors are also uricosuric. These pleiotropic effects of SGLT2 inhibitors are likely to have contributed to the results of the EMPA-REG OUTCOME trial in which the SGLT2 inhibitor, empagliflozin, slowed the progression of chronic kidney disease and reduced major adverse cardiovascular events in high-risk individuals with type 2 diabetes. This review discusses the role of SGLT2 in the physiology and pathophysiology of renal glucose reabsorption and outlines the unexpected logic of inhibiting SGLT2 in the diabetic kidney." @default.
• W2553261268 created "2016-11-30" @default.
• W2553261268 creator A5020811053 @default.
• W2553261268 creator A5085734264 @default.
• W2553261268 date "2016-11-22" @default.
• W2553261268 modified "2023-10-12" @default.
• W2553261268 title "Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition" @default.
• W2553261268 cites W1408949075 @default.
• W2553261268 cites W1528664908 @default.
• W2553261268 cites W1603802113 @default.
• W2553261268 cites W1664963969 @default.
• W2553261268 cites W172609984 @default.
• W2553261268 cites W1770274352 @default.
• W2553261268 cites W1888211049 @default.
• W2553261268 cites W1963696315 @default.
• W2553261268 cites W1972653282 @default.
• W2553261268 cites W1990025047 @default.
• W2553261268 cites W1996132147 @default.
• W2553261268 cites W1997018189 @default.
• W2553261268 cites W2002760082 @default.
• W2553261268 cites W2007832417 @default.
• W2553261268 cites W2013448178 @default.
• W2553261268 cites W2014077044 @default.
• W2553261268 cites W2016103822 @default.
• W2553261268 cites W2020151823 @default.
• W2553261268 cites W2021517048 @default.
• W2553261268 cites W2021825265 @default.
• W2553261268 cites W2023244494 @default.
• W2553261268 cites W2027545319 @default.
• W2553261268 cites W2030311010 @default.
• W2553261268 cites W2033212729 @default.
• W2553261268 cites W2033807650 @default.
• W2553261268 cites W2041205525 @default.
• W2553261268 cites W2055237726 @default.
• W2553261268 cites W2064918807 @default.
• W2553261268 cites W2068225029 @default.
• W2553261268 cites W2077038286 @default.
• W2553261268 cites W2077636750 @default.
• W2553261268 cites W2088289833 @default.
• W2553261268 cites W2089939599 @default.
• W2553261268 cites W2096294438 @default.
• W2553261268 cites W2100796772 @default.
• W2553261268 cites W2106340518 @default.
• W2553261268 cites W2108588975 @default.
• W2553261268 cites W2109728760 @default.
• W2553261268 cites W2112710337 @default.
• W2553261268 cites W2113507924 @default.
• W2553261268 cites W2120600312 @default.
• W2553261268 cites W2128219379 @default.
• W2553261268 cites W2128814368 @default.
• W2553261268 cites W2130570549 @default.
• W2553261268 cites W2131411448 @default.
• W2553261268 cites W2133469996 @default.
• W2553261268 cites W2135705997 @default.
• W2553261268 cites W2138364630 @default.
• W2553261268 cites W2141228342 @default.
• W2553261268 cites W2142593697 @default.
• W2553261268 cites W2144862658 @default.
• W2553261268 cites W2146264128 @default.
• W2553261268 cites W2148958160 @default.
• W2553261268 cites W2149973065 @default.
• W2553261268 cites W2150192337 @default.
• W2553261268 cites W2150392479 @default.
• W2553261268 cites W2152413054 @default.
• W2553261268 cites W2153839551 @default.
• W2553261268 cites W2157373537 @default.
• W2553261268 cites W2157405334 @default.
• W2553261268 cites W2158482469 @default.
• W2553261268 cites W2159258864 @default.
• W2553261268 cites W2160471487 @default.
• W2553261268 cites W2164080605 @default.
• W2553261268 cites W2164368208 @default.
• W2553261268 cites W2166613497 @default.
• W2553261268 cites W2167245776 @default.
• W2553261268 cites W2169403426 @default.
• W2553261268 cites W2171784381 @default.
• W2553261268 cites W2215784195 @default.
• W2553261268 cites W2230682495 @default.
• W2553261268 cites W2238341693 @default.
• W2553261268 cites W2265269529 @default.
• W2553261268 cites W2290070720 @default.
• W2553261268 cites W2305012287 @default.
• W2553261268 cites W2309487596 @default.
• W2553261268 cites W2409027410 @default.
• W2553261268 cites W2412800896 @default.
• W2553261268 cites W2416348735 @default.
• W2553261268 cites W2424539745 @default.
• W2553261268 cites W2465054738 @default.
• W2553261268 cites W2512006388 @default.
• W2553261268 cites W2769264260 @default.
• W2553261268 cites W4242364069 @default.
• W2553261268 doi "https://doi.org/10.1007/s00125-016-4157-3" @default.
• W2553261268 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5884445" @default.
• W2553261268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27878313" @default.
• W2553261268 hasPublicationYear "2016" @default.
• W2553261268 type Work @default.
• W2553261268 sameAs 2553261268 @default.
• W2553261268 citedByCount "376" @default.

• next